Bristol Myers Squibb (BMY) reported strong Q4 earnings earlier in February, and prospects remain strong for 2025, although it may face some…
Category:
Stocks
-
-
As “economic softening” increasingly emerges as the prevailing narrative driving the markets, the retail sector occupies a peculiar space amid these shifts…
-
In this video, Dave breaks down bearish macro signals and risk management using the “line in the sand” technique! Learn how to…